Which class of drugs is most commonly given to clients with Immune Thrombocytopenic Purpura (ITP)?

The most commonly prescribed class of drugs for clients with Immune Thrombocytopenic Purpura (ITP) is steroids and immunosuppressive agents. The primary goal in treating ITP is to increase the platelet count and reduce the immune system's attack on platelets. Steroids, such as prednisone, are often used because they can help decrease inflammation and suppress the immune response that is causing the destruction of platelets. This helps stabilize the condition and can lead to an increase in platelet production and retention.

Immunosuppressive agents may also be utilized, especially in chronic cases where steroids alone are not effective. These medications act on the immune system to further prevent the destruction of platelets and additionally can be beneficial for patients who have not responded adequately to steroids.

In contrast, antibiotics and antivirals are used to treat infections, which are not directly related to the management of ITP. Analgesics and antipyretics are primarily for pain and fever relief, and they do not address the underlying issue of low platelet counts in ITP. Vasodilators and anticoagulants are generally contraindicated in ITP since they can exacerbate bleeding tendencies associated with this condition.